[1] Demakis JG,Rahimtoola SH,Sutton GC,et al.Naturralcourse of Peripartum cardiomyopathy [J].Circulation,1971,44(6):1053-1061. [2] Pfeffer TJ, Hilfiker KD. Pregnancy and heart disease: pregnancy-associated hypertension and peripartum cardiomyopathy[J]. Curr Probl Cardiol, 2018,43(9):364-388. [3] Islgai T, Kamiya CA. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality[J]. Int Heart J,2019,60(3):503-511. [4] Sliwa K, Petrie MC, Hilfiker-Kleiner D, et al. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartumcardiomyopathy: practical guidance paper from the heart failure association of the European Society of Cardiology study group on peripartum cardiomyopathy[J]. Eur J Heart Fail, 2018, 20(6): 951-962. [5] Irizarry OC, Levine LD, Lewey J, et al. Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women[J]. J Am Med Assoc Cardiol, 2017, 2(11): 1256-1260. [6] Sliwa K, Hilfiker-Kleiner D, Mebazaa A, et al. EUR observational research programme: a worldwider egistry on peripartum cardiomyopathy(PPCM) in conjunction with the heart failure association of the European Society of Cardiology working group on PPCM[J]. Eur J Heart Fail, 2014, 16(5): 583-591. [7] Isezuo SA,Abubakar SA.Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital[J].Ethn Dis,2007,17(2):228-233. [8] 郭潇潇,刘永太,方理刚,等.围产期心肌病的临床特点及预后分析[J].中华内科杂志,2016,55(2):127-130. [9] Karaye KM, Ishaq NA,Sa'idu H.Incidence,clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry[J]. ESC Heart Failure,DOI:10.1002/ehf2.12562. [10] Stergiopoulos K,Lima FV.Peripartum cardiomyopathy-diagnosis,management,and long term implications[J].Trends Cardiovasc Med,2019,29(3):164-173. [11] Banayan J,Rana S,Mueller A,et al.Cardiogenic shock in pregnancy:analysis from the National Inpatient Sample[J].Hypertens Pregnancy,2016,36(2):117-123. [12] Hibbard JU,Lindheimer M,Lang RM.A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography[J].Obstet Gynecol,1999,94(2):311-316. [13] Pearson GD,Veille JC,Rahimtoola S,et al.Peripartum cardiomopathy:National Heart,Lung,and Blood Institute and Office of Rare Diseases(NationalInstitutes of Health) workshop recommendations and review[J].JAMA,2000,283:1183-1188. [14] Chapa JB,Heiberger HB,Weinert L,et al.Prognostic value of echocardiography in peripartum cardiomyopathy[J].Obstet Gynecol,2005,105(6):1303-1308. [15] Goland S,Modi K,Bitar F,et al.Clinical profile and predictors of complications in peripartum cardiomyopathy[J].J Card Fail,2009,15(8):645-650. [16] Elkayam U,Tummala PP,Rao K,et al.Maternal and fetaloutcomes of subsequent pregnancies in women with peripartum cardiomyopathy[J].N Engl J Med,2001,344(21):1567-1571. [17] Sliwa K,Hilfiker-Kleiner D,Petrie MC,et al.Current state of knowledge on aetiology,diagnosis,management,and therapy of peripartum cardiomyopathy:a position statement fromthe Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy[J].Eur J Heart Fail,2010,12(8):767-778. [18] Ponikowski P, Voors AA, Anker SD,et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Kardiol Pol,2016,74(10):1037-1147. [19] Melinda D,Claire D.Peripartum cardiomyopathy:current knowledge and future directions[J]. Women's Health,2015,11(4):565-573. [20] Hilfiker-Kleiner D,Haghikia A,Nonhoff J,et al.Peripartum cardiomyopathy:current management and future perspectives[J]. Eur Heart J,2015,36:1090-1097. [21] Stapel B,Kohlhaas M,Ricke-Hoch M,et al.Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy[J].Eur Heart J,2017,38(5): 349-361. [22] Labbene I,Arrigo M,Tavares M,et al.Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy[J].Anaesth Crit Care Pain Med,2017,36(1):39-42. [23] Bauersachs J,Arrigo M,Hilfiker Kleiner D,et al.Current management of patients with severe acute peripartum cardiomyopathy:practical guidance from the Heart Failure Association of the European society of cardiology study group on peripartum cardiomyopathy[J].Eur J Heart Fail,2016,18(9):1096-1105. [24] Jackson AM,Dalzell JR,Walker NL,et al.Peripartum cardiomyopathy:diagnosis and management[J].Heart,2018,104(9):779-786. |